Vitamins E, C Inversely Linked to Risk for Parkinson Disease
Dietary vitamin E and vitamin C intake may be inversely associated with Parkinson disease risk.
Parkinson Disease
Therapies Which Enhance PLCG2 Activity May Be Effective in Treating Parkinson and Alzheimer Diseases
The study authors sought to determine which components of the peripheral immune response correlated with diagnoses of Alzheimer or Parkinson Disease.
Researchers Explore Gene Regulatory Pathways and Neurological Disease
Study results provide new insight into how neuron subtypes outside the substantia nigra pars compacta may be compensating at a molecular level for differences in the motor production neural circuit during the progression of Parkinson’s disease.
Air Pollution Tied to Neurological Disorders in Seniors
Exposure to air pollution is associated with an increased risk for neurological disorders in older adults.
Prenatal Cannabis Use Associated With Psychopathology in Middle Childhood
A study suggests prenatal cannabis exposure and its correlated factors are associated with greater risk for psychopathology during middle childhood.
Stem Cell-Derived Neurons Provide Clues Into Parkinson Disease
After transplanting hESC-derived midbrain dopamine into the striatum of a PD model mouse, researchers found extensive graft integration with host circuitry.
COVID-19 Mortality Higher in Patients With Parkinson Disease
COVID-19-related case fatality rates are higher for patients with Parkinson disease, independent of age, sex, and race.
Kynmobi Now Available to Treat Off Episodes in Parkinson Disease
Apomorphine is believed to treat off episodes associated with PD through stimulation of postsynaptic dopamine D2-type receptors within the caudate-putamen in the brain.
Ongentys Now Available as Add-On Treatment for Parkinson Disease
Ongentys is an oral, selective and reversible inhibitor of catechol-O-methyltransferase.
New Drug Application for Apomorphine Infusion Pump Submitted for Review
The NDA for SPN-830 is supported by data from an extensive development program that includes the phase 3 TOLEDO study and a supportive open-label study.
-
Loading...
-
Loading...
Next post in Movement Disorders
